79 related articles for article (PubMed ID: 3520946)
1. [Detection of low numbers of malignant cells in patients with leukemia or non-Hodgkin lymphoma: use of immunological markers].
van Dongen JJ; Hooijkaas H; Adriaansen HJ; Hählen K; van Zanen GE
Tijdschr Kindergeneeskd; 1986 Apr; 54(2):41-5. PubMed ID: 3520946
[TBL] [Abstract][Full Text] [Related]
2. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections.
Orazi A; Cattoretti G; John K; Neiman RS
Mod Pathol; 1994 Jun; 7(5):582-6. PubMed ID: 7937725
[TBL] [Abstract][Full Text] [Related]
3. [Terminal deoxynucleotidyltransferase (TdT)-positive cells in cerebrospinal fluid of children with leukemia or non-Hodgkin lymphoma: implications for the diagnosis of central nervous system leukemia].
Hooijkaas H; Adriaansen HJ; Hählen K; van Zanen GE; van Dongen JJ
Tijdschr Kindergeneeskd; 1986 Apr; 54(2):46-50. PubMed ID: 3520947
[TBL] [Abstract][Full Text] [Related]
4. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction.
van Dongen JJ; Breit TM; Adriaansen HJ; Beishuizen A; Hooijkaas H
Leukemia; 1992; 6 Suppl 1():47-59. PubMed ID: 1548936
[TBL] [Abstract][Full Text] [Related]
5. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma.
Suzumiya J; Ohshima K; Kikuchi M; Takeshita M; Akamatsu M; Tashiro K
J Pathol; 1997 May; 182(1):86-91. PubMed ID: 9227346
[TBL] [Abstract][Full Text] [Related]
6. [Significance of terminal deoxynucleotidyl transferase in patients with acute leukemia and malignant lymphoma: results obtained by immunofluorescence assay (author's transl)].
Ho AD; Hunstein W; Uhl N; Storch HH
Dtsch Med Wochenschr; 1981 May; 106(20):643-7. PubMed ID: 7014159
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric identification of intracellular antigens: detection of minimal residual leukemia.
Gore S; Kastan M; Civin C
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():39-41. PubMed ID: 1697192
[TBL] [Abstract][Full Text] [Related]
8. Terminal deoxynucleotidyl transferase activity in non-hematologic and hematologic neoplasms.
Castella A; Davey FR; Kurec AS; Thompson NA
Ann Clin Lab Sci; 1982; 12(5):403-7. PubMed ID: 6958214
[TBL] [Abstract][Full Text] [Related]
9. Detection of terminal transferase in acute myeloid leukemia by flow cytometry.
Paietta E; Meenan B; Heavey C; Thomas D
Cytometry; 1994 Jul; 16(3):256-61. PubMed ID: 7924695
[TBL] [Abstract][Full Text] [Related]
10. [Demonstration of terminal deoxynucleotidyl transferase in histological sections].
Steinmann G; Müller-Hermelink HK
Klin Padiatr; 1983; 195(3):230-3. PubMed ID: 6348396
[TBL] [Abstract][Full Text] [Related]
11. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
[TBL] [Abstract][Full Text] [Related]
12. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice.
Asjö B; Skoog L; Palminger I; Wiener F; Isaak D; Cerny J; Fenyö EM
Cancer Res; 1985 Mar; 45(3):1040-5. PubMed ID: 3871660
[TBL] [Abstract][Full Text] [Related]
13. Detection of terminal deoxynucleotidyl transferase (TdT) in nonhematopoietic small round cell tumors of children.
Mathewson RC; Kjeldsberg CR; Perkins SL
Pediatr Pathol Lab Med; 1997; 17(6):835-44. PubMed ID: 9353824
[TBL] [Abstract][Full Text] [Related]
14. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
Shumak KH; Baker MA; Taub RN; Coleman MS
Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
[TBL] [Abstract][Full Text] [Related]
15. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
16. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of leukemia cell terminal transferase measurements.
McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
[TBL] [Abstract][Full Text] [Related]
18. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
[TBL] [Abstract][Full Text] [Related]
19. Terminal transferase surveillance of remission bone marrows in childhood acute lymphoblastic leukemia: improved sensitivity with countercurrent centrifugal elutriation.
Lauer SJ; Lyman S; Kirchner PA; Gottschall JL; Camitta BM; Casper JT
J Clin Lab Immunol; 1985 Jan; 16(1):17-22. PubMed ID: 3856682
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
